JBIO (Jade Biosciences) Accounts Payable: $3.98 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $19.14
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Accounts Payable?

Jade Biosciences JBIO -3.09% 12 Accounts Payable is $3.98 Mil as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Jade Biosciences's Accounts Payable for the quarter that ended in Mar. 2026 was $3.98 Mil.

Jade Biosciences's quarterly Accounts Payable increased from Sep. 2025 ($1.35 Mil) to Dec. 2025 ($2.15 Mil) and increased from Dec. 2025 ($2.15 Mil) to Mar. 2026 ($3.98 Mil).

Jade Biosciences's annual Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($1.29 Mil) and increased from Dec. 2024 ($1.29 Mil) to Dec. 2025 ($2.15 Mil).

Jade Biosciences Accounts Payable Related Terms

Jade Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Accounts Payable Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Accounts Payable
1.29 2.15

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial 0.00 7.59 1.35 2.15 3.98
JBIO
12GF Score
Jade Biosciences Inc JBIO
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $3.98 Mil mean?
Jade Biosciences (JBIO) has a Accounts Payable of $3.98 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Jade Biosciences and its competitors.
Is Jade Biosciences' Accounts Payable too high?
Jade Biosciences' current Accounts Payable is $3.98 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Accounts Payable compare to NVAX and AVLN?
Jade Biosciences' Accounts Payable of $3.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Accounts Payable is $3.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Accounts Payable of $3.98 Mil. The current Accounts Payable is $3.98 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Accounts Payable is $3.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.14
Price